 | Up a level |
Jochmans, Dirk; Liu, Cheng; Donckers, Kim; Stoycheva, Antitsa; Boland, Sandro; Stevens, Sarah K; De Vita, Chloe; Vanmechelen, Bert; Maes, Piet; Trüeb, Bettina; Ebert, Nadine; Thiel, Volker; De Jonghe, Steven; Vangeel, Laura; Bardiot, Dorothée; Jekle, Andreas; Blatt, Lawrence M; Beigelman, Leonid; Symons, Julian A; Raboisson, Pierre; ... (2023). The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir. mBio, 14(1), e0281522. American Society for Microbiology 10.1128/mbio.02815-22
Chiu, Winston; Schepers, Joost; Francken, Thibault; Vangeel, Laura; Abbasi, Kayvan; Jochmans, Dirk; De Jonghe, Steven; Thibaut, Hendrik Jan; Thiel, Volker; Neyts, Johan; Laporte, Manon; Leyssen, Pieter (2023). Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery. Antiviral research, 210, p. 105506. Elsevier 10.1016/j.antiviral.2022.105506
Fenwick, Craig; Turelli, Priscilla; Perez, Laurent; Pellaton, Céline; Esteves-Leuenberger, Line; Farina, Alex; Campos, Jérémy; Lana, Erica; Fiscalini, Flurin; Raclot, Charlène; Pojer, Florence; Lau, Kelvin; Demurtas, Davide; Descatoire, Marc; Joo, Victor S; Foglierini, Mathilde; Noto, Alessandra; Abdelnabi, Rana; Foo, Caroline S; Vangeel, Laura; ... (2021). A highly potent antibody effective against SARS-CoV-2 variants of concern. Cell reports, 37(2), p. 109814. Cell Press 10.1016/j.celrep.2021.109814
